Category: Intellectual property
-
Start-Up Developing Microbial Cancer Detection Tests
A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples.
-
Breath Analysis Sensor Licensed to Detect Covid-19
Discoveries in a university lab that enable detection of Covid-19 infections from a person’s breath are being licensed for development by a biotechnology company.
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.
-
Start-Up Developing Inside-Cell Delivery, Gains $28.5M
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells.
-
Tough Surgical Adhesive Commercially Licensed
A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab.
-
Univ. Lab Discovers, Licenses Citrus Disease Treatment
Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a disease destroying citrus crops worldwide.
-
Non-Invasive Fetal Oxygen Monitor Designed
A university engineering lab created a device that safely monitors a fetus’s blood oxygen levels from outside the mother’s abdomen, which could reduce the rate of cesarean sections.
-
Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.